Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD

Files
Kantak Dwoskin 2016.pdf(49.04 KB)
Accepted manuscript
Date
2016-06
Authors
Kantak, Kathleen M.
Dwoskin, Linda P.
Version
OA Version
Citation
Kathleen M. Kantak, Linda P. Dwoskin. "Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD.." Pharmacol Biochem Behav, v. 145, pp. 24 - 26.
Abstract
Controversy continues regarding increased vulnerability for addiction to cocaine and other drugs of abuse in adulthood following the use of stimulant medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The results of recent research utilizing an animal model of ADHD strongly advocate for a closer look at this important issue in clinical populations, particularly where treatment is initiated in adolescence, and with certain ADHD medications.
Description
License
Attribution-NonCommercial-NoDerivatives 4.0 International